Valeant faces U.S. Senate probe of three drugs that saw prices skyrocketCommittee on aging scrutinizing three other drug companies as well. U.K. junior doctors refuse 11% pay hike following strike threatJunior doctors reject offer accusing the government of megaphone diplomacy over good faith negotiations Catastrophic pharmacare is a catastrophe Why the provinces don’t need $3 billion in federal tax dollars for flawed prescription drug policies. Valeant sends letter in an attempt to reassure U.S. health care professionals Company offers reassurance patients will continue to have access to medicines. Helping immigrant nurses a ‘win-win’ for Canada: study Alberta injects additional $301 million for physician compensation and development Canada’s Valeant faces intense pressure in U.S. Drug pricing scandal in States puts our RX darling under the microscope. Sue government, then what? An Ontario pharmacist warns doctors One thing we can look forward to in the new Canada is the oncoming, all-consuming war on the private sector. States: Walgreens-Rite Aid deal a threat to smaller drugstores Association representing independent pharmacies urges regulators to scrutinize merger. N.S. residents head to arbitration: Premier disappointed at 'premature' move New model for AFP contract being used in N.S. Academic funding plan talks will use agreed-upon national comparators for physician pay issues First Previous 329 330 331 332 333 Next Last
